Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Osteosarcoma × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 134 Breast Neoplasms 36 Prostatic Neoplasms 30 Insulin Resistance 28 Obesity 18 Pancreatic Neoplasms 14 Neoplasms 13 Endometrial Neoplasms 13 Infertility 12 Colorectal Neoplasms 12 Carcinoma, Non-Small-Cell Lung 12 Anovulation 10 Lung Neoplasms 9 Neoplasm Metastasis 8 Glioblastoma 8 Metabolic Syndrome 7 Hyperandrogenism 7 Diabetes Mellitus 7 Squamous Cell Carcinoma of Head and Neck 6 Melanoma 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 5 Lymphoma, Large B-Cell, Diffuse 5 Brain Neoplasms 5 Adenocarcinoma 5 Weight Loss 4 Rectal Neoplasms 4 Ovarian Neoplasms 4 Mouth Neoplasms 4 Head and Neck Neoplasms 4 Diabetes Mellitus, Type 2 4

Interventions

Ifosfamide 29 Methotrexate 27 Doxorubicin 25 Cyclophosphamide 23 Cisplatin 21 Etoposide 16 Filgrastim 15 Gemcitabine 14 Leucovorin 12 Magnetic Resonance Spectroscopy 11 Temozolomide 9 Specimen Handling 9 fludarabine 8 apatinib 8 X-Rays 8 Nivolumab 8 Neoadjuvant Therapy 8 Irinotecan 8 Granulocyte Colony-Stimulating Factor 8 Carboplatin 8 Zoledronic Acid 7 Sirolimus 7 Radiotherapy 7 Phantoms, Imaging 7 Drug Therapy 7 Docetaxel 7 Biopsy 7 mifamurtide 6 cabozantinib 6 Vincristine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04758000 2023-08-04

Metform-Bone

Istituto Ortopedico Rizzoli

Phase 2 Recruiting

Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡